Achieving the lowest false-negative rate in peritumoral breast lymphatic mapping: the oncologic search for the Holy Grail.
Kern
Kenneth A
KA
D001943:Breast Neoplasms / Q000473:pathology*; D004396:Coloring Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis / Q000175:diagnosis*; D015203:Reproducibility of Results; D021701:Sentinel Lymph Node Biopsy / Q000379:methods / Q000592:standards*
D004396:Coloring Agents